Dr. Eakin serves as the principal investigator on every study at OCT and specializes in streamlining the design and execution of Phase 1 studies. She has experience in shaping protocols to maximize efficiency while minimizing costs and shortening timelines. She also has expertise in Phase 2 and 3 studies and has access to specialists in a broad range of therapeutic areas.